WTX212

1 product

1 abstract

Abstract

WTX212, an erythrocyte-anti-PD1 antibody conjugate, to demonstrate anti-tumor activities in tumor models and patients with cancer with acquired resistance to immunotherapy.

Org: Westlake University, Westlake Institute for Advanced Study, Westlake Therapeutics Co., Ltd.,

Product